Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D003913:Dextroamphetamine / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors*; D004347:Drug Interactions; D008297:Male; D008781:Methyltyrosines / Q000008:administration & dosage / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology*; D009043:Motor Activity / Q000187:drug effects*; D009638:Norepinephrine / Q000378:metabolism; D010668:Phenylthiazolylthiourea / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors*
D008781:Methyltyrosines; D010668:Phenylthiazolylthiourea; D009020:Morphine; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine